You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Extensive-stage small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Extensive Stage Small Cell Lung Cancer

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer hospital
    Aug 6, 2023

    Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
    • (no location specified)
    Sep 19, 2023

    Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer
    • hSTC810 400 mg + Paclitaxel
    • hSTC810 800 mg + Paclitaxel
    • (no location specified)
    Aug 24, 2023

    Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

    Recruiting
    • SCLC,Extensive Stage
    • PD-(L)1 antibody immunotherapy
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Jul 3, 2023

    Small Cell Lung Cancer Trial in Cleveland (Alisertib)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Cleveland, Ohio
      Cleveland Clinic
    Oct 18, 2023

    Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

    Recruiting
    • Extensive-stage Small Cell Lung Cancer
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 27, 2023

    Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • (no location specified)
    May 22, 2023

    Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

    Not yet recruiting
    • Small Cell Lung Cancer
    • +2 more
    • (no location specified)
    Jun 5, 2023

    Durvalumab in Combination With Standard Chemotherapy of

    Recruiting
    • Small-cell Lung Cancer
    • Extensive-stage Small-cell Lung Cancer
      • Néo Fáliro, Greece
        Metropolitan Hospital
      Mar 7, 2023

      Outcomes ofBrazilian Cohort of Previously Untreated Extensive

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Observational study
      • (no location specified)
      Aug 24, 2023

      Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • Large Cell Neuroendocrine Carcinoma of the Lung
      • LB2102
      • (no location specified)
      Jan 10, 2023

      Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Sydney, New South Wales, Australia
      • +6 more
      Mar 21, 2023

      Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Fuzhou, Fujian, China
        Fujian Cancer Hospital
      May 20, 2023

      Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

      Recruiting
      • Extensive Stage Small Cell Lung Cancer
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Jun 6, 2023

      Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Changchun, Jilin, China
        Jilin Cancer Hospital
      Jun 21, 2023

      Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

      Not yet recruiting
      • Small Cell Lung Cancer
      • +2 more
      • Association of lurbinectedin and durvalumab
      • Association of carboplatin and etoposide
      • Bordeaux, France
        Institut Bergonié
      Oct 5, 2022

      Extensive-stage Small-cell Lung Cancer Trial in Hangzhou (QL1706, Carboplatin, Etoposide)

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Jul 13, 2022

      Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • quaratusugene ozeplasmid
      • atezolizumab
      • (no location specified)
      Jan 19, 2023

      Lung Cancer, Extensive-stage Small-cell Lung Cancer, Radiotherapy Trial (Durvalumab + carboplatin/cisplatin + etoposide,

      Not yet recruiting
      • Lung Cancer
      • +2 more
      • Durvalumab + carboplatin/cisplatin + etoposide
      • +2 more
      • (no location specified)
      Aug 3, 2022

      Extensive-Stage Small Cell Lung Cancer Trial in Beijing (Surufatinib, Anti-PD-1/L1)

      Not yet recruiting
      • Extensive-Stage Small Cell Lung Cancer
      • Beijing, China
        Chinese PLA General Hospital
      Aug 18, 2022

      Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Durvalumab 50 MG/1 ML Intravenous Solution
      • +4 more
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Oct 31, 2022

      Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • Jinan, China
      • +2 more
      Sep 10, 2023

      SCLC, Extensive Stage Trial in Tianjin (DLL3-CAR-NK cells)

      Recruiting
      • SCLC, Extensive Stage
      • DLL3-CAR-NK cells
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute and Hospital
      Aug 18, 2022

      Extensive-stage Small-cell Lung Cancer Trial (Surufatinib Durvalizumab EP/EC)

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Surufatinib Durvalizumab EP/EC
      • (no location specified)
      Dec 20, 2022

      Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

      Recruiting
      • Extensive Stage Small Cell Lung Cancer
      • Lille, France
      • +6 more
      Jan 23, 2023